Therapy for foetal pericardial tumours: survival following in utero shunting, and literature review.
We report the first case of foetal pericardial teratoma, treated successfully in utero by pericardio-amniotic shunting, and review the relevant literature. Foetal treatment improves survival in case of hydrops. Foetal pericardio-amniotic shunting could possibly be an alternative to serial pericardiocentesis.
Devlieger
R
R
Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium. roland.devlieger@uz.kuleuven.ac.be
Hindryckx
A
A
Van Mieghem
T
T
Debeer
A
A
De Catte
L
L
Gewillig
M
M
Gucciardo
L
L
Deprest
J
J
Meyns
B
B
D000328:Adult; D006348:Cardiac Surgical Procedures; D002305:Cardiac Tamponade / Q000196:embryology / Q000628:therapy; D002404:Catheterization; D002585:Cesarean Section; D005260:Female; D006338:Heart Neoplasms / Q000000981:diagnostic imaging / Q000196:embryology / Q000628:therapy*; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology / Q000628:therapy; D007231:Infant, Newborn; D010490:Pericardial Effusion / Q000196:embryology / Q000628:therapy; D020519:Pericardiocentesis; D010496:Pericardium / Q000196:embryology / Q000601:surgery; D011247:Pregnancy; D056346:Sternotomy; D013724:Teratoma / Q000000981:diagnostic imaging / Q000196:embryology / Q000628:therapy*; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler; D016216:Ultrasonography, Prenatal